Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers

OBJECTIVE: To identify an early response criterion for predicting ≥5% weight loss with liraglutide 3.0 mg at week 56 and to compare efficacy outcomes in early responders (ERs) and early nonresponders (ENRs). METHODS: Using pooled data from the SCALE Obesity and Prediabetes and SCALE Diabetes trials,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Obesity (Silver Spring)
Main Authors: Fujioka, Ken, O'Neil, Patrick M., Davies, Melanie, Greenway, Frank, C.W. Lau, David, Claudius, Birgitte, Skjøth, Trine Vang, Bjørn Jensen, Christine, P.H. Wilding, John
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Obesity Symposium
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129670/
https://ncbi.nlm.nih.gov/pubmed/27804269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.21629
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados